Blog
Washington just bought Intel—and sold capitalism
Back in 2010, I testified before Congress against reauthorizing the so-called America COMPETES Act. That legislation was the precursor to the much-ballyhooed CHIPS and…
Blog
The week in regulations: Bird hunting and food coloring
The Federal Register’s website became less transparent about rule counts and other data. President Trump threatened to send the military into a third city. The…
Blog
DC Circuit Court shields proxy advisor duopoly
In an unfortunate move, the DC Circuit Court of Appeals recently struck down the Securities and Exchange Commission’s (SEC) 2020 Proxy Advisor Rule. The…
Blog
The harm is the process: Unconstitutional NLRB proceedings halted
The Fifth Circuit Court of Appeals threw a wrench into the gears of the National Labor Relations Board (NLRB) this week, and for good reason.
Blog
Free the Economy podcast: Subsidies for billionaires with David McGarry
In this week’s episode we cover White House intervention in corporate ownership, the nation’s falling economic freedom ranking, and welcome new…
Blog
The current state of pharmaceutical tariffs
Background Amid the Trump trade upheaval, pharmaceutical products receive different treatment than many other US imports. Pharmaceuticals are treated differently for reasons such as their…